Blue Shield of California President and CEO Paul Markovich Statement Supporting the New California Prescription Drug Transparency Law
By a
High drug prices remain a significant threat to affordability of health care for all Californians.
Health plans and hospitals are required to publicly share detailed information about their prices, price increases, and profits. SB 17 logically and thoughtfully extends this disclosure to drug companies, thereby reducing the likelihood that they will increase their prices numerous times throughout the year - with no explanation other than the fact that it can be done.
As a nonprofit health plan whose mission is to provide all Californians access to quality healthcare that's sustainably affordable, we are proud to be in a state where the governor and Legislature are leading the way in helping to make that a reality. Background on
Keywords for this news article include: Legal Issues, Managed Care,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC
New Findings in Medicare Described from NBER (Do health insurers innovate? Evidence from the anatomy of physician payments)
New Health Insurance Study Results Reported from City University of New York (Estimating The Effects Of Health Insurance And Other Social Programs On…
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News